Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details)

v3.22.2.2
Stockholders' Equity (Details) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended
Dec. 20, 2021
Nov. 30, 2021
Jan. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Nov. 29, 2021
Nov. 24, 2021
Stockholders' Equity (Details) [Line Items]                    
Common shares authorized (in Shares)       500,000,000   500,000,000        
Description of authorized capital stock           (i) 495,000,000 shares of common stock having a par value of $0.0001 per share and (ii) 5,000,000 shares of preferred stock having a par value of $0.0001 per share.        
Private placement amount     $ 1,000,000              
Sale shares (in Shares)     625,000              
Price per shares (in Dollars per share)     $ 1.6              
Shares issued (in Shares)           395,625        
Aggregate proceeds received           $ 633,000        
Issued shares (in Shares)                 8,680,000  
Warrants to purchase (in Shares)                 8,680,000  
Cash fee   9.00%                
Accountable expenses   $ 70,000                
Offering price per (in Dollars per share)           $ 3.5        
Aggregate gross proceeds           $ 30,380,000        
Underwriter discounts and fees           $ 27,000,000        
Warrants remain outstanding (in Shares)           8,680,000        
Weighted average remaining life           9 years 6 months        
Aggregate intrinsic value           $ 0        
Stock based compensation expense       $ 100,000 $ 300,000 200,000 $ 300,000      
Remaining unamortized compensation       $ 700,000   $ 700,000        
Weighted average grant date fair value (in Dollars per share)           $ 0.45        
Volatility percentage           40.40%        
Risk-free interest rate           3.20%        
Fair value of expected term           6 years 6 months        
Stock option granted price (in Dollars per share)           $ 1        
Restricted stock awards expense         $ 15,000   15,000      
Common stock issued (in Shares)       26,698,688   26,698,688   23,008,371    
Common stock outstanding (in Shares)       26,698,688   26,698,688   23,008,371    
Warrants [Member]                    
Stockholders' Equity (Details) [Line Items]                    
Warrants to purchase (in Shares)       1,000,000   1,000,000        
Risk-free interest rate           3.38%        
Fair value of expected term           5 years        
Exercise price (in Dollars per share)           $ 1.88        
Exercisable term           5 years        
Fair value of stock price exercise price (in Dollars per share)           $ 0.35        
Fair value amount           $ 400,000        
Warrant per value (in Dollars per share)       $ 0.35   $ 0.35        
Fair value of volatility           55.70%        
Minimum [Member]                    
Stockholders' Equity (Details) [Line Items]                    
Investors election percentage           4.99%        
Maximum [Member]                    
Stockholders' Equity (Details) [Line Items]                    
Investors election percentage           9.99%        
Second Private Placement [Member]                    
Stockholders' Equity (Details) [Line Items]                    
Private placement amount             $ 5,000,000      
Sale shares (in Shares)             2,083,333      
Price per shares (in Dollars per share)         $ 2.4   $ 2.4      
Shares issued (in Shares)           239,969        
Aggregate proceeds received           $ 576,000        
Restricted Stock Units (RSUs) [Member]                    
Stockholders' Equity (Details) [Line Items]                    
Stock based compensation expense       $ 24,000   48,000        
Remaining unamortized compensation       240,000   240,000        
Stock option granted (in Shares) 200,000                  
Stock option granted price (in Dollars per share) $ 1.44                  
Restricted Stock [Member]                    
Stockholders' Equity (Details) [Line Items]                    
Stock based compensation expense       400,000   400,000        
Remaining unamortized compensation       $ 500,000   $ 500,000        
Shares issued (in Shares)       429,447   429,447        
Common stock issued (in Shares)       4,294,477   4,294,477        
Common stock outstanding (in Shares)       4,294,477   4,294,477        
November 2021 Private Placement [Member]                    
Stockholders' Equity (Details) [Line Items]                    
Issued shares (in Shares)                   8,680,000
Warrants to purchase (in Shares)                   8,680,000
Purchase price (in Dollars per share)           $ 3.5        
Warrants term       5 years   5 years        
Exercise per share (in Dollars per share)       $ 3.5   $ 3.5        
Cash fee   1.00%